Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Nimustine Hydrochloride for Injection

Approval Number

国药准字H20058694

Company吉斯美（武汉）制药有限公司

Registration Date

March 3, 2022

Previous Approval Numbers

国药准字H20058694

Drug Information

Generic Name

注射用盐酸尼莫司汀

Dosage Form

注射剂

Strength

50mg

Drug Type

化学药品

Registration Date

March 3, 2022

Company Information

Applicant Company

Company Name吉斯美（武汉）制药有限公司

Company Address

武汉东湖新技术开发区高新大道858号生物医药园

Manufacturing Company

Company Name吉斯美（武汉）制药有限公司

Company Address

湖北省武汉市东湖新技术开发区关南工业园

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy